PFIZER
It is finally time for PFE?After many years of consolidation is PFE finally got "star" fame?
Like we can see monthly chart it's almost close to make a beautiful reversal Head and Shoulder chart for strong push up on fundamentals wings.
As pandemic subside and hope that Covid-19 pass through behind ours backs, forward P/E and revenues is strong on PFE side, so buy area will be good setup for as the Redditors would say "PFE to the moon" haha...
Thank you very much for reading, if you see that this chart is interesting and feel free to press like and comment, every comment is welcome :)
NYSE:PFE
Breakout if it holds above 130.As you can see from the chart, the RSI is oversold, which means one thing. Breakout season! Now you have heard me say this all the time but a breakout is coming! You can see on every time the RSI has oversold, it has led to all-time highs or breakouts of their patterns. Brace yourself because i bet we are gonna breakout either this month or March and if it breaks below, expect to see support levels at 128,126 and 123. Warning! I am not a financial adviser and take this with a grain of salt. Happy trading!
Looks like PFE it's going to break upFrom the technical point of view, if PFE breaks the resistance level noted in this chart it can go easily over 40$ USD after earnings.
There's no reason to short Pfizer right now. The company got massive amount of money from vaccine pre-orders, investments and probably the earnings will be at last at estimated level.
Pfizer forming a double bottom to continue moving up?Another update on PFE. Price has stalled for some time now around the internal support. We have a divergence with RSI and the price and RSI is starting to move above 50. MACD is making a bullish crossing and the histogram is going positive as well. Volumes are showing buying activity and we have a potential setup for a double bottom. Keep an eye on PFE.
Ex-dividend date - An end to investors' hesitation?Good evening.
Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off.
Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says
Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February.
Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021.
P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more.
Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?
Pfizer long confirmedIn addition to the portfolio long on Pfizer will be added as the session starts. Double doji candles and MACD crossover and RSI is rising above 50 are enough as confirmation. I've been tracking PFE since the end of December and now an opportunity to buy stocks of the company has revealed. My target is $44 - $44.80.
VTRS healthcare sleeper? Healthcare company that was formed by the combination of Mylan and Pfizer's Upjohn Business and is presenting Thursday 1/14 at JPM health conference . Also announced their inaugural investor day March 1st where we could see a deep dive into the companies value and deliver potential long term value for shareholders... might be a good time load shares on the breakout of this downtrend, options have no liquidity.
Pfizer Analysis. 3 reasons to watch.Hello Everyone,
I hope you all had a good start to the New Year.
Pfizer (PFE) has been in the news a lot recently due to their vaccine. There may also be a few reasons to keep an eye on their stock price.
1) Support/Resistance- PFE ended the year with a pull-back. The price is currently being supported around $37. Price has hit resistance at $37 three times since May 2020. Price broke through the resistance in Nov 2020 and appears to be forming a new support in this range.
2) Fibonacci Retracement- This support/resistance area ($37) also coincides with a 61.8% retracement from the most recent low from Oct 2020 (see attached chart). Price has not closed below the 61.8% retracement as of writing.
3) MACD Divergence- Looking at the MACD/price chart, the MACD is diverging from the price. Hidden Bullish Divergence formed on the price chart/MACD at $37. This may further prove price has found a new support at $37.
I would personally like to see a close above the 50-day EMA prior to entering any trades so I will continue to watch closely.
Thank you for reading and please do your own research before trading
PFIZERWednesday, 6 January 2021
10:55 AM (WIB)
PFIZER is on the way to distributes Vaccines over the world.
After escapes from the huge Descending Channel, Pfizer creates a new Ascending Channel with the best momentum to rise higher from now.
Best regards,
RyodaBrainless
"Live to Ride and Ride to Live"
Pfizer Pfizer and BioNTech companies have offered to supply 50 million doses of their COVID-19 vaccine to Africa for healthcare workers. The vaccine will be delivered in batches from March to the end of 2021.
Meanwhile, Pfizer had broken through the downtrend resistance line and then tested it. The price moves in an ascending channel and the most pleasant entry point is 36.6 if you know what I mean.
BioNTech
Best regards EXCAVO
US100 Nasdaq EEUU US500
I hope they are well. From L.E.D we wish you a Happy and Prosperous New Year, and good health !!!
In Spain on 01/04/2021